The ISET® technology has been developed by a team of physicians and scientists from the company Rarecells Diagnostics  spinoff of the University Paris Descartes  AP-HP (Assistance Publique-Hôpitaux de Paris) and INSERM (Institut National de la Santé et de la Recherche Médicale) working to improve the life of cancer patients